Literature DB >> 22375877

Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo.

Qing-Hao Zhang1, Jin-Ping Hu, Bao-Lian Wang, Yan Li.   

Abstract

Capsaicin and dihydrocapsaicin, the two most abundant members of capsaicinoids in chili peppers, are widely used as food additives and for other purposes. In this study, we examined the inhibitory potentials of capsaicin and dihydrocapsaicin against CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4/5 activities in human liver microsomes. The effects of these two capsaicinoids on CYP450 enzymes were also evaluated in vivo in rats. The results demonstrated that capsaicin and dihydrocapsaicin moderately inhibited five isozymes (IC₅₀) values ranging from 4.4 to 61.8 μM), with the exception of CYP2E1 (IC₅₀ > 200 μM). Both capsaicinoids exhibited competitive, mixed, and noncompetitive inhibition on these isozymes (K (i) = 3.1 ± 0.5 - 78.6 ± 8.4 μM). Time-dependent inhibition of CYP3A4/5 by capsaicin was found. After multiple administrations of capsaicin and dihydrocapsaicin (1, 4, and 10 mg/kg) to rats, chlorzoxazone 6-hydroxylase activity and the expression of CYP2E1 were increased in liver microsomes. Our findings indicated that the possibility of food-drug interactions mediated by capsaicin and dihydrocapsaicin could not be excluded, and provided the useful information for evaluating the anticarcinogenic potentials of these two capsaicinoids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22375877     DOI: 10.1080/10286020.2012.656605

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  2 in total

1.  Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China.

Authors:  Tianbo Jin; Hua Yang; Jiayi Zhang; Zulfiya Yunus; Qiang Sun; Tingting Geng; Chao Chen; Jie Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis.

Authors:  Peijian Wang; Zhencheng Yan; Jian Zhong; Jing Chen; Yinxing Ni; Li Li; Liqun Ma; Zhigang Zhao; Daoyan Liu; Zhiming Zhu
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.